[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"neuromuscular-blockade-monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:neuromuscular-blockade-monitoring":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,68,93],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100649983","monitoring-of-neuromuscular-blockade-in-the-intensive-care-unit-a-reliability-study-100649983",false,"NCT07741851","Monitoring of Neuromuscular Blockade in the Intensive Care Unit: a Reliability Study","CURAREA","Inclusion Criteria:\n\n* Adult patients\n* Patients admitted to the intensive care unit who have been receiving neuromuscular blocking agents for at least 24 hours during their stay - Consent obtained from the patient or emergency consent obtained from family members\n* Patients covered by the French social security system, regardless of the specific plan\n\nExclusion Criteria:\n\n* Patients who have already been exposed to prolonged neuromuscular blockade or who have been receiving continuous neuromuscular blockade for less than 24 hours\n* Allergy to neuromuscular blocking agents\n* Patients with a neurological condition that alters the interpretation of neuromuscular blockade or contraindicates the use of neuromuscular blocking agents\n* Patients enrolled in an interventional study\n* Patients who object to the collection of their medical data for this study\n* Patients under the age of 18\n* Patients deprived of their liberty, under guardianship, or under conservatorship\n* Pregnant or breastfeeding women","ALL","18 Years",{"count":19,"type":20},160,"ESTIMATED","INTERVENTIONAL",[23],"NA","The objective of this clinical trial is to evaluate the reliability of neuromuscular blockade monitoring in adult intensive care patients depending on the clinical context.\n\nThe main questions it aims to answer are as follows:\n\n* Detection of an anomaly at ulnar \"TOF\" stimulation in patients without neuromuscular blockade\n* Absence of adverse events during clinical monitoring of neuromuscular blockade (every 24 hours): absence of respiratory effort movements or patient-ventilator asynchrony (safety)",[26],"Neuromuscular Blockade Monitoring",[28,29,30,31],"intensive care","neuromusculare blockade monitoring","cisatracurium","TOF","RECRUITING","2026-07-28",{"date":35,"type":36},"2026-08-03","ACTUAL",{"date":38,"type":36},"2026-04-02",{"date":40,"type":20},"2027-01",{"name":42,"class":43},"Centre Hospitalier Intercommunal Aix-Pertuis","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":44},"100623246","nmt-easyfit-sensor-and-cable-100623246","NCT07394140","NMT EasyFit Sensor and Cable","Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable","Inclusion Criteria:\n\n1. Study subject (male or female) is age 18 years or older (≥18 years).\n2. Study subject must have the ability to understand and provide written informed consent.\n3. Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.\n4. Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand\u002Fforearm.\n\nExclusion Criteria:\n\n1. Are known to be pregnant.\n2. Are breastfeeding.\n3. Suffering from an infection(s) that requires isolation.\n4. Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.\n5. Subjects requiring rapid sequence induction\n6. Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.\n7. Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).\n8. NMT ElectroSensor placed on the foot\u002Fankle",{"count":53,"type":20},30,[23],"The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.",[26,57],"NMT","2026-07-06",{"date":60,"type":36},"2026-07-08",{"date":62,"type":36},"2026-06-18",{"date":64,"type":20},"2026-12-31",{"name":66,"class":67},"GE Healthcare","INDUSTRY",{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":76,"targetDuration":4,"studyType":21,"phases":78,"briefSummary":79,"conditions":80,"keywords":4,"overallStatus":83,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":44},"100628641","effect-of-neuromuscular-block-depth-on-driving-pressure-and-postoperative-respiratory-events-in-abdominal-surgeries-100628641","NCT07464288","Effect of Neuromuscular Block Depth on Driving Pressure and Postoperative Respiratory Events in Abdominal Surgeries","The Effect of Different Depths of Neuromuscular Blockade, Assessed by Train of Four (TOF) Monitoring, On Driving Pressure and the Development of Postoperative Critical Respiratory Events in Abdominal Surgeries","Inclusion Criteria:\n\n* Elective abdominal surgery under general anesthesia that is expected to last longer than one hour\n* ASA I-II-III\n* Age ≥18 years\n* Written informed consent\n\nExclusion Criteria:\n\n* Refusal to participate in the study\n* ASA ≥ IV\n* Age \\\u003C18\n* Obesity (BMI\\>30) and cachexia (BMI \\\u003C18)\n* Laparoscopic surgery\n* Emergency procedure\n* Allergy to drugs used during induction and maintenance of general anesthesia\n* Presence of psychiatric\u002Fneurologic\u002Fneuromuscular disease\n* Risk of malignant hyperthermia or having any relative with history of malignant hyperthermia\n* Use of medications that may affect neuromuscular function (anticonvulsants, aminoglycosides, magnesium salts, etc.)\n* Pregnancy\n* Presence of advanced chronic lung disease (asthma, COPD, etc.)\n* Presence of advanced liver and renal disease (creatinine\\>1.6, liver function tests above twice the normal range)",true,{"count":77,"type":20},128,[23],"This randomized controlled study aims to evaluate the effects of deep versus moderate neuromuscular blockade on intraoperative driving pressure and the development of postoperative critical respiratory events in patients undergoing abdominal surgery under general anesthesia.",[81,26,82],"Driving Pressure","Postoperative Respiratory Complications","NOT_YET_RECRUITING","2026-03-15",{"date":86,"type":36},"2026-03-17",{"date":88,"type":20},"2026-03-23",{"date":90,"type":20},"2026-04-24",{"name":92,"class":43},"Ankara City Hospital Bilkent",{"id":94,"slug":95,"hasResults":11,"nctId":96,"briefTitle":97,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":100,"enrollmentInfo":101,"targetDuration":4,"studyType":21,"phases":103,"briefSummary":104,"conditions":105,"keywords":107,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":44},"100621496","the-tof3d-mechanomyograph-evaluation-of-a-new-device-for-assessment-of-the-neuromuscular-block-100621496","NCT07371377","The TOF3D Mechanomyograph. Evaluation of a New Device for Assessment of the Neuromuscular Block.","MMG versus AMG","Inclusion Criteria:\n\n* patients scheduled for surgery requiring general anesthesia with neuromuscular blocking agents\n\nExclusion Criteria:\n\n* anticipated or known difficult airway\n* increased risk for aspiration\n* pregnancy\n* neuromuscular disorders","65 Years",{"count":102,"type":20},50,[23],"In clinical anesthesiologic practice, most institutions use acceleromyography in order to assess the degree of a neuromuscular block.\n\nThe aim of the present study is to assess a new device using mechanomyography. Until recently, this method was reserved for experimental settings. It seems to be able to work more precisely, and additionally, it offers the opportunity to use other stimulation patterns than acceleromyographic measurements.\n\nThe investigation is divided into two parts:\n\nPart 1 compares the mechanomyograph directly with an acceleromyograph. In part 2, two mechanomyographs using different stimulation patterns are compared with each other.",[106,26],"Mechanomyography",[108,109],"mechanomyography","tetanic fade","2026-01-19",{"date":112,"type":36},"2026-01-27",{"date":114,"type":36},"2026-01-09",{"date":116,"type":20},"2027-07",{"name":118,"class":43},"Klinikum Hersfeld-Rotenburg"]